Previous vaccination strategies in malaria achieved 5- to 10-fold higher IFN-γ–secreting, Ag-specific T cell responses in humans than responses induced by a DNA vaccine or recombinant MVA vaccine alone, and produced similar results with partial protection against malaria manifesting as delayed parasitemia after sporozoite challenge (56). The gene discussed is IFNG; the disease is malaria.